X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
Morgan Stanley reported a 9.40% stake in X4 Pharmaceuticals, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 12, 2026
Morgan Stanley reported a 9.40% stake in X4 Pharmaceuticals, Inc., 8,196,489 shares, as a passive investor on Dec 31, 2025. Filed Feb 12, 2026 (Schedule 13G).
- Stake
- 9.40%
- Shares
- 8,196,489
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 9.40% | 8,196,489 |
| Morgan Stanley Investment Management Inc. | 9.40% | 8,196,455 |
Source
Related
- X4 Pharmaceuticals, Inc.
- Morgan Stanley
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Mar 6, 2026
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026